A generic alternative indicated for Skin Care. Managing the symptoms of atopic dermatitis, this preparation promotes skin barrier restoration and reduces localized inflammatory responses.
Intended to alleviate eczema flares and address chronic itching in patients where standard steroid treatments are not suitable or recommended.
Mechanism of Action
This medication works by dampening the immune response in the skin. It blocks the activation of T-cells and stops the release of chemicals that cause redness, swelling, and itching associated with dermatitis.
Route of Administration
Topical
Onset Time
1–2 weeks
Contraindications
Active skin infection, Weakened immune system, History of skin cancer, Netherton's syndrome
Severe Adverse Events
Risk of skin malignancy, Lymphoma (rare warning), Severe skin infection, Widespread warts
Information for Pimecrolimus 1% is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
